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Summary
Background China has achieved Millennium Development Goal 4 to reduce under-5 mortality rate by two-thirds between 
1990 and 2015. In this study, we estimated the national and subnational levels and causes of child mortality in China 
annually from 1996 to 2015 to draw implications for achievement of the SDGs for China and other low-income and 
middle-income countries.
Methods In this systematic analysis, we adjusted empirical data on levels and causes of child mortality collected in the 
China Maternal and Child Health Surveillance System to generate representative estimates at the national and 
subnational levels. In adjusting the data, we considered the sampling design and probability, applied smoothing 
techniques to produce stable trends, ﬁ tted livebirth and age-speciﬁ c death estimates to natvional estimates produced 
by the UN for international comparison, and partitioned national estimates of infrequent causes produced by 
independent sources to the subnational level.
Findings Between 1996 and 2015, the under-5 mortality rate in China declined from 50·8 per 1000 livebirths to 
10·7 per 1000 livebirths, at an average annual rate of reduction of 8·2%. However, 181 600 children still died before 
their ﬁ fth birthday, with 93 400 (51·5%) deaths occurring in neonates. Great inequity exists in child mortality across 
regions and in urban versus rural areas. The leading causes of under-5 mortality in 2015 were congenital abnormalities 
(35 700 deaths, 95% uncertainty range [UR] 28 400–45 200), preterm birth complications (30 900 deaths, 24 200–40 800), 
and injuries (26 600 deaths, 21 000–33 400). Pneumonia contributed to a higher proportion of deaths in the western 
region of China than in the eastern and central regions, and injury was a main cause of death in rural areas. Variations 
in cause-of-death composition by age were also examined. The contribution of preterm birth complications to 
mortality decreased after the neonatal period; congenital abnormalities remained an important cause of mortality 
throughout infancy, whereas the contribution of injuries to mortality increased after the ﬁ rst year of life.
Interpretation China has achieved a rapid reduction in child mortality in 1996–2015. The decline has been widespread 
across regions, urban and rural areas, age groups, and cause-of-death categories, but great disparities remain. The 
western region and rural areas and especially western rural areas should receive most attention in improving child 
survival through enhanced policy and programmes in the Sustainable Development Goals era. Continued investment 
is crucial in primary and secondary prevention of deaths due to congenital abnormalities, preterm birth complications, 
and injuries nationally, and of deaths due to pneumonia in western rural areas. The study also has implications for 
improving child survival and civil registration and vital statistics in other low-income and middle-income countries.
Funding Bill & Melinda Gates Foundation.
Copyright © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license.
Introduction
2015 marked the end of the Millennium Development 
Goal (MDG) era and the beginning of the implementation 
of the Sustainable Development Goals (SDGs). China 
represents a unique example of success in achieving the 
MDG 4 target of reducing under-5 mortality rate by two-
thirds between 1990 and 2015. Based on estimates 
published by the UN Interagency Group on Child 
Mortality Estimation (UN IGME), China’s under-5 
mortality rate declined from 53·8 to 10·7 per 
1000 livebirths at an average annual rate of reduction 
(ARR) of 6·5% in 1990–2015, faster than the ARR needed 
to achieve the MDG 4 target of 4·4%.1 In fact, China 
achieved the MDG 4 target in 2009, 6 years ahead of time. 
China is also one of about only a dozen countries that 
achieved a faster decline of mortality in neonates than in 
children aged 1–59 months since 1990.1,2
In this Article, we estimated the national and subnational 
levels and causes of child mortality in China annually in 
1996–2015, and attempted to draw implications for 
achievement of the SDGs for China and other low-income 
and middle-income countries (LMICs). We updated our 
approach to estimating causes of child deaths in China 
from the previous single-cause models based on 
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published data3 to use of adjusted empirical data from 
the Maternal and Child Health Surveillance System 
(MCHSS).
Methods
Study design and participants
MCHSS is a sample registration system collecting vital 
statistics on levels and causes of maternal and child 
mortality and data on congenital abnormalities. The 
system is designed to be nationally and regionally 
representative. A child mortality surveillance network 
was ﬁ rst established in 1991 by the Ministry of Health in 
China. In 1996, child mortality surveillance was 
combined with the maternal mortality and congenital 
abnormality surveillance networks to form MCHSS. 
Since then, MCHSS has been generating estimates on 
levels and causes of child mortality at the national and 
regional level.4,5
In 1991, the child mortality surveillance network covered 
a population of 8·5 million in 81 cities or counties. When 
MCHSS was established in 1996, the system was expanded 
to 116 surveillance sites covering 37 urban districts and 
79 rural counties in 31 provinces, autonomous regions, 
and municipalities, monitoring a total population of 
12·7 million in mainland China.6 A major expansion of 
MCHSS was initiated in 2006 because of rapidly declining 
rates of maternal and child mortality. Training and quality 
assessments were done in new sites in 2006–08. Data 
from new sites have been incorporated since 2009. After 
the expansion, MCHSS came to its current structure in 
2013, covering 334 sites representing 124 urban districts 
and 210 rural counties with a surveillance population of 
47·1 million (ﬁ gure 1). Additional details of the MCHSS 
evolution are in the appendix (p 3).
MCHSS has a multistage, stratiﬁ ed, clustered sampling 
design; stratiﬁ cation changed over time.6,7 The sampling 
design and sample size calculation before 2006 are in the 
appendix (pp 4–5). When MCHSS expanded in 2006, the 
sample size was calculated based on infant mortality 
from MCHSS in 2005, crude birth rate from the National 
Bureau of Statistics in 2005, total population from the 
2000 national census, and a design eﬀ ect of 2·0 to adjust 
for correlation of events within the sampled areas (see 
appendix p 6 for more details).
The sampling was also updated in 2006. The country 
was divided into eastern, central, and western regions, 
and each region was further stratiﬁ ed into urban and rural 
areas (appendix p 7). The urban or rural classiﬁ cation was 
derived from criteria used in the 1993 National Health 
Services Survey and the 2006 administrative division 
codes published by the National Bureau of Statistics.8,9 
MCHSS is thus regarded to be representative of the 
six region-residency strata: eastern urban, eastern rural, 
central urban, central rural, western urban, and western 
rural areas, and of the aggregates of the six strata. The 
original surveillance sites remained in the sample. New 
sites added in 2006 were randomly sampled from urban 
neighbourhoods and rural townships covering 10% of the 
Research in context
Evidence before this study
We searched multiple databases such as PubMed, Embase, ISIS 
Web of Knowledge, Popline, and LILACS for studies that 
reported causes of deaths in children younger than 5 years in 
China published up to Feb 12, 2015. There were no language 
restrictions. Twelve eligible studies that reported causes of 
death in China for children younger than 5 years were identiﬁ ed. 
Two studies were nationally representative, reporting causes of 
deaths in children younger than 5 years for some years in 
1996–2010. Ten studies reported data only for selected years 
and subnational geographic areas. In 2015, we published the 
county level under-5 mortality estimates for China for the years 
1996–2012. We used data from the Maternal and Child Health 
Surveillance System (MCHSS), censuses, surveys, surveillance 
sites, and disease surveillance points. We also published in 2010 
causes of child mortality for China in 2008, in which input data 
for the estimation were based on systematic review of 
peer-reviewed publications.
Added value of this study
In this study, we updated and improved our estimates from the 
previous two papers on levels and causes of child mortality, 
speciﬁ cally to 1996–2015, to present China’s progress in 
improving child survival in the era of the Millennium 
Development Goals. We introduce in detail the MCHSS, which is 
regarded as the highest quality data source among all sources 
used previously. We adjusted the empirical estimates from 
MCHSS, with the adjustment and estimation methods being 
largely independent of the previous estimation approaches. We 
found that estimates presented in this Article agree in general 
with our previous estimates for the same years. Additionally, we 
highlighted areas where more research is needed to understand 
the key factors that contributed to China’s progress in most of 
the MDG period. Our research has implications for China and 
other low-income and middle-income countries (LMICs) to 
achieve the Sustainable Development Goals.
Implications of all the available evidence
China has made impressive and widespread progress in 
improving child survival in 1996–2015, and the establishment 
and evolution of the MCHSS have been important in 
documenting this progress. Establishment of the sample 
registration system and its improvement over time could be 
useful for other LMICs that do not have quality vital and sample 
registration systems. However, more rigorous research is 
needed to fully understand the eﬀ ects of China’s child-survival 
policy and programmes implemented during this period, which 
could be adopted by other LMICs.
See Online for appendix
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total population of the newly sampled urban districts and 
rural counties.
All children under 5 years of age, living in the 
surveillance sites and all livebirths of mothers who are 
either permanent residents of the sites or have lived in 
the sites for at least 1 year are included in MCHSS. There 
were no exclusion criteria. A livebirth was deﬁ ned as a 
fetus of at least 28 weeks’ gestation (or with birthweight 
of more than 1000 g if the gestational age was 
unknown), and showing any of the following signs of life 
after separation from his or her mother: heartbeat, 
breathing, umbilical cord pulsation, or voluntary muscle 
contraction.6 Livebirths were recorded by community 
health workers in urban areas or village doctors in rural 
areas and reported to neighbourhood (urban) or township 
(rural) Maternal and Child Health Centers (MCHCs) on 
Figure 1: China Maternal and Child Health Surveillance System site map
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a monthly basis. The information was compiled by 
district (urban) or county (rural) MCHCs and reported to 
higher (than district or county) level (city, prefecture, and 
province) MCHCs on a quarterly basis.
Outcomes
The recording and reporting of deaths and causes of 
deaths were implemented in both communities and 
health facilities. Details of the reporting and cause 
ascertainment have been published elsewhere.10 Brieﬂ y, 
deaths occurring in communities were recorded and 
reported to township MCHCs within 10 days of the 
events by village doctors. Deaths and causes of deaths 
were then investigated, ascertained, and reported using 
the Child Death Registration Card (appendix pp 8–9) by 
township MCH physicians within the next 7 days. Cause 
ascertainment was based on death certiﬁ cates of children 
who died in health facilities, the last clinical diagnosis if 
children were discharged from health facilities within 
1 month of death and died on their way home or at home, 
or verbal autopsy if there was no contact with the health-
care system (the distribution of deaths by cause 
ascertaining method by age and year are in the appendix 
[p 10]). Verbal autopsy was done using non-standardised 
instruments before 2012, and the 2012 WHO verbal 
autopsy instrument and physician review from 2012 
onwards.11 Deaths occurring in health facilities were 
recorded on the Child Death Registration Card on site 
and reported quarterly to district or county MCHCs. 
Information on deaths and causes of deaths was then 
compiled by district or county MCHCs and crosschecked 
between community and facility reports for duplicates or 
missing records on a quarterly basis. Health-facility 
reports not conﬁ rmed by community reports were 
further investigated to ensure they were eligible MCHSS 
cases. Once crosschecked, deaths and causes of deaths 
were reported to higher level MCHCs on a quarterly 
basis. Since 2007, internet-based reporting has been 
implemented in parallel with paper-based reporting and 
both systems are currently in use.6,10,12
Quality control
Coverage, completeness, and validity of reported live-
births, deaths, and causes of deaths were reviewed at the 
neighbourhood or township level quarterly, and at the 
district or county and higher levels annually. An annual 
quality control study is done by the MCHSS national 
oﬃ  ce in two selected provinces.10 Provinces rotate through 
the quality control study over time. Three surveillance 
sites, including one urban and two rural sites from each 
province, are randomly selected. All child deaths occurring 
in those sites are reviewed by the MCHSS National Oﬃ  ce. 
Data triangulation is done at all levels of MCHSS through 
cross-validation of reported births and deaths through 
multiple sources to identify missing events. These sources 
include local health facilities, family planning oﬃ  ces, 
Centers of Disease Control, and public security 
bureaus.6,10,12 Since 2010, the neonatal death audit has been 
implemented in MCHSS (see appendix p 11 for details).
Rates of under-reporting for livebirths and child deaths 
were calculated as the fraction of missed cases identiﬁ ed in 
the annual quality control study out of total cases captured 
(appendix p 11). The rate of under-reporting of livebirths 
was less than 1·5% in urban areas and less than 3% in rural 
areas in 1996–2015. Rates of under-reporting were less than 
1% in the eastern region, less than 4% in the central region, 
and less than 3·5% in the western region. The rates of 
under-reporting of under-5 deaths were 10–30% at the 
national level, 10–25% in the eastern region, 12–35% in the 
central region, and 16–33% in the western region.
Data analysis
Before 2014, information on causes of deaths was 
collected and grouped into 35 categories in MCHSS 
(appendix p 9). These categories were mapped to 
aggregated codes of the International Classiﬁ cation of 
Diseases 10th version (ICD-10) during the analyses 
(appendix pp 12–14). Since 2014, causes of deaths have 
been directly coded using ICD-10 in MCHSS. Causes 
were further mapped and aggregated to the Child Health 
Epidemiology Reference Group categories in this study.13,14
In this study, MCHSS data are available annually for the 
period 1996–2015. We adjusted MCHSS empirical data to 
generate nationally and subnationally representative 
estimates of the numbers of deaths and mortality rates of 
deaths by cause. Speciﬁ cally, we ﬁ rst adjusted the annual 
number of deaths by cause using a 3 year moving average 
of under-reporting rates by age group (0–6 days, 7–27 days, 
28 days–5 months, 6–11 months, 12–23 months, and 
24–59 months), type of residency (urban or rural), and 
region (eastern, central, or western). We calculated 
sampling probabilities based on best available estimate of 
the total population under surveillance and the region-
residency census population (appendix p 15). For 1996, we 
based the total population on the 1990 national census, 
whereas the population under surveillance was based on 
the 1996 MCHSS. For 2000 and 2010, we based the total 
population on national censuses and the population under 
surveillance on MCHSS data in the corresponding years. 
The sampling probability ranged from 0·4% in rural 
central regions in 1996 to 6·6% in urban western regions 
in 2010. The sampling probabilities increased consistently 
in 2010, and more so in rural strata. We applied the 
sampling probabilities to the number of livebirths in 
MCHSS to derive livebirth estimates for each region-
residency stratum such that the 1996 probabilities were 
applied to livebirths estimates for 1996–99, the 2000 
probabilities were applied to 2000–09, and the 2010 
probabilities were applied to 2010 onwards. We then 
normalised stratum-speciﬁ c livebirths to the UN’s 
estimates of livebirths for China15 at the national level 
proportionally to ensure global and regional comparability 
and smoothed stratum-speciﬁ c proportions of livebirths 
using a 3 year moving average to obtain stable trends.
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We calculated the total numbers of all-cause deaths by 
age-region-residency strata using region-residency-
speciﬁ c livebirths deﬁ ned above, and a 3 year moving 
average of age-region-residency-speciﬁ c all-cause mortality 
rates. We normalised the total numbers of stratiﬁ ed all-
cause deaths to ﬁ t the total number of deaths of neonates 
and 1–59-month-old children generated by UN IGME for 
1996–2015.1 Within each age-region-residency stratum, we 
smoothed the cause-speciﬁ c mortality fractions using a 
7 year moving average, with the highest weight given to 
the fourth year and the lowest and equal weights given to 
the ﬁ rst and seventh year. We then calculated the numbers 
of deaths by cause based on the smoothed cause-speciﬁ c 
mortality fractions and age-region-residency-speciﬁ c all-
cause deaths.
Deaths due to infrequent causes, including HIV or 
AIDS, pertussis, malaria, and measles, were challenging 
to capture in MCHSS. We used WHO programme 
estimates for these causes instead.2 We derived 
subnational estimates for these causes assuming the 
number of cause-speciﬁ c deaths were distributed 
similarly to all-cause deaths across strata.2 Although the 
assumption could be problematic for localised infectious 
epidemic such as malaria, the total numbers of deaths 
due to these conditions were rather small (eg, 3–8 malaria 
deaths were estimated in 1996–2015). Therefore, biases 
associated with this assumption are likely to be small. 
The numbers and fractions of all the causes were 
normalised to all-cause deaths within each age-region-
residency stratum. Subnational estimates were 
aggregated to derive regional and national estimates.
Comparison with other estimates, uncertainty 
estimation, and transparency
We compared our estimates with those produced by 
systematic analysis16 for the period 2009–15. The analysis16 
was based on a systematic review of Chinese scientiﬁ c 
literature that included all published studies meeting 
prespeciﬁ ed inclusion criteria on causes of child 
mortality,16 and was an update of our previous estimates 
applying single-cause models to derive cause-speciﬁ c 
mortality fractions for the period 2000–08.3,14 These 
estimates are based on nearly 300 studies published from 
a subset of MCHSS sites.1 Because input data are not 
exactly the same and the estimation strategies of the 
two approaches have limited overlap, the two sets of 
estimates are partially independent. We used accuracy of 
cause-speciﬁ c mortality fractions17 to measure the 
population-level agreement between the two sets of 
estimates on cause distribution. Cause-speciﬁ c mortality 
fraction accuracy is scaled between 0 and 1 (1 indicating 
perfect agreement).
The uncertainty of estimated deaths by cause for each 
year, and the uncertainty in the time trend was estimated 
by incorporating resampling methods of the bootstrap.18 
The stratiﬁ ed total number of surveillance sites was 
selected at random with replacement in each region over 
1000 independent instances, building a distribution for 
possible observed causes of deaths in each stratum. The 
2·5th and 97·5th percentiles of this bootstrapped 
distribution were used as the uncertainty bounds for the 
numbers of deaths by cause.
This study conforms to the Guidelines for Accurate and 
Transparent Health Estimates Reporting (GATHER) 
statement,19 which promotes transparency and replicability 
of global health estimates (see appendix p 16 for checklist). 
Figure 2: Age-speciﬁ c mortality rates in children younger than 5 years in China, 1996–2015
(A) National. (B) By region. (C) By residency. UR=uncertainty range.
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Additional details of the input data, estimation 
methodology including statistical codes, and estimates are 
online and publicly available through the Maternal and 
Child Epidemiology Estimations website.
Role of the funding source
The funder of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. All coauthors involved in the 
analyses had access to the data in the study and the 
corresponding authors had ﬁ nal responsibility for the 
decision to submit for publication.
Results
In 2015, 181 600 children died before the age of 5 in China, 
with 93 400 (51·5%, 95% uncertainty range [UR] 
44·0–60·0) occurring in the neonatal period. At the 
national level, under-5 mortality rate fell by nearly 80% in 
the past two decades, from 50·8 deaths per 1000 livebirths 
in 1996 to 10·7 per 1000 livebirths in 2015 (ﬁ gure 2A), 
resulting in an ARR of 8·2% per year (table 1). Neonatal 
mortality rate also declined substantially, from 25·7 deaths 
per 1000 livebirths in 1996 to 5·5 per 1000 livebirths in 
2015. The rate of decline was faster in the ﬁ rst decade than 
in the second decade for under-5 mortality rate, but 
steadier for neonatal mortality rate (ﬁ gure 2A).
Child mortality rates showed large variation by region 
in 1996–2015 (ﬁ gure 2B). The western region had the 
highest under-5 mortality rate and neonatal mortality 
rate in 2015, with an estimated under-5 mortality rate of 
18·5 (95% UR 12·6–25·2) deaths per 1000 livebirths and 
neonatal mortality rate of 9·5 (6·8–13·7) per 
1000 livebirths. The under-5 mortality rate in the eastern 
region was 5·8 deaths per 1000 livebirths and neonatal 
mortality rate in the eastern region was 3·1 per 
1000 livebirths, similar to the rates in the USA and 
Canada. The geographical inequalities, represented by 
the ratio of under-5 mortality rate and neonatal mortality 
rate between western and eastern regions, ﬂ uctuated but 
generally increased during this period. For example, the 
ratio of under-5 mortality rate increased from 2·9:1 in 
1996 to 4·4:1 in 2004, dropped to 2·3:1 in 2005–2010, then 
increased again to 3·2:1 in 2015. Since 1996, under-5 
mortality rate in all three regions have been decreasing 
with an ARR of 7·5% or greater; the central region had 
the fastest ARR of 8·5% (95% UR 6·8–10·8; table 1).
Inequity in child mortality between rural and urban 
areas was also apparent in China in 1996–2015 
(ﬁ gure 2C). In 2015, 81·1% (95% UR 80·9–81·4) of 
under-5 deaths occurred in rural China. This proportion 
reduced from 96·2% (93·5–96·5) in 1996, which is 
probably reﬂ ective of rapid urbanisation. As a result, 
despite a continued reduction in under-5 mortality rate 
in urban areas (by 56·5% [39·5–68·2] between 1996 and 
2015), the actual number of under-5 deaths occurring in 
urban areas increased by 27·2% (9·7–40·6). In rural 
areas, mortality rates fell by more than 75% for neonates 
National Eastern region Central region Western region
All cause
Under-5 mortality rate 8·2% (6·4–9·7) 8·1% (6·4–9·6) 8·5% (6·8–10·8) 7·5% (5·8–9·0)
Under-5 mortality rate 
in urban areas
4·4% (2·8–6·0) 6·0% (4·4–7·6) 4·1% (2·6–5·8) 4·5% (2·8–6·1)
Under-5 mortality rate 
in rural areas
7·9% (6·2–9·4) 7·9% (6·2–9·4) 8·6% (6·8–10·0) 6·7% (5·0–8·2)
Early neonatal 
mortality rate
8·4% (5·0–9·1) 8·6% (6·9–11·0) 9·4% (7·7–11·8) 6·7% (5·0–9·1)
Late neonatal 
mortality rate
7·1% (4·9–9·0) 7·9% (6·2–10·3) 7·0% (5·3–9·4) 6·6% (4·9–9·0)
Neonatal mortality 
rate
8·1% (6·4–10·5) 8·5% (5·9–10·8) 8·9% (7·2–11·3) 6·6% (5·0–9·0)
Infant mortality rate 7·2% (5·3–8·6) 7·1% (5·9–9·2) 7·7% (6·5–9·8) 6·5% (5·3–8·6)
By cause
Neonatal tetanus 26·4% (22·2–39·3) 23·7% (8·6–29·8) 34·0% (9·4–42·7) 20·8% (16·4–30·5)
Diarrhoea 12·8% (10·1–15·7) 12·9% (9·3–19·1) 15·5% (11·7–19·9) 11·7% (8·8–14·9)
Pneumonia 11·4% (9·7–13·7) 12·5% (9·4–16·7) 12·4% (10·5–15·0) 10·3% (8·3–12·8)
Measles 9·4% (6·9–14·1) 8·7% (5·8–13·1) 9·2% (6·7–13·9) 9·4% (8·0–15·3)
Injury 9·3% (5·4–9·6) 9·2% (5·8–10·4) 9·3% (5·2–9·6) 8·5% (3·7–10·2)
Intrapartum-related 
conditions
8·6% (6·3–10·5) 8·5% (5·6–10·2) 8·6% (7·3–11·5) 8·1% (4·3–9·1)
Sepsis or meningitis 8·0% (5·9–10·6) 7·6% (5·0–11·9) 9·1% (5·5–11·0) 6·4% (4·4–11·0)
Preterm birth 
complications
6·6% (5·0–9·1) 6·9% (5·2–9·5) 8·3% (6·6–10·9) 4·5% (2·6–7·2)
Congenital 
abnormalities
4·1% (2·3–6·1) 6·5% (4·6–9·1) 3·5% (1·4–6·2) 2·6% (0·0–6·2)
Other conditions 7·0% (5·9–9·7) 6·8% (4·6–8·7) 6·7% (5·8–9·3) 7·0% (5·5–9·9)
Data are annual rate of reduction (95% uncertainty range). 
Table 1: National and regional average annual rate of reduction and uncertainty range of all-cause 
mortality rates and cause-speciﬁ c mortality rates in children younger than 5 years in China, 1996–2015
Figure 3: Causes of deaths in children aged 1–59 months and neonates in China, 2015
Causes of death that caused less than 1% of all deaths are not labelled.
Congenital
abnormalities 10·4%
Other conditions 10·3%
Pneumonia 9·3%
Preterm birth complications 16·0%
Other conditions 4·9%
Injury 2·5%
Congenital abnormalities 9·2%
Sepsis or meningitis 1·4%
Intrapartum-related 
events 14·1%
Pneumonia 3·0%
Diarrhoea 2·7%
Injury 12·1%
Meningitis 1·1%
Preterm birth  
complications 1·1%
Neonates (51·5%)Children aged 1–59 months (48·5%)
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(77·5% [68·1–82·4]) and children aged under-5 years 
(77·8% [67·9–80·2]).
The leading causes of under-5 mortality in 2015 in 
China were congenital abnormalities (19·7% [95% UR 
18·1–21·5]), preterm birth complications (17·0% 
[14·9–19·7]), and injuries (14·6% [13·4–15·8]) (ﬁ gure 3; 
table 2). The leading causes in neonates were preterm 
birth complications (16·0% [13·7–18·9] of under-5 
deaths), intrapartum-related events (14·1% [12·1–16·6]), 
and congenital abnormalities (9·2% [8·0–11·1]). 
Among children aged 1–59 months, the leading causes 
were injuries (12·1% [10·6–13·5]), congenital 
abnormalities (10·4% [8·0–12·6]), and pneumonia 
(9·3% [6·9–11·0]).
The contribution of major infectious causes, such as 
pneumonia and diarrhoea, to all-cause under-5 deaths 
decreased from 1996 to 2015 (ﬁ gure 4). Pneumonia was 
the leading cause of death in 1996, accounting for 22·6% 
(95% UR 20·8–25·3) of all-cause under-5 deaths (table 2). 
The contribution of pneumonia dropped to 12·2% 
(10·1–13·8), making it the 6th leading cause in 2015. The 
proportion of deaths due to diarrhoea decreased from 
6·9% (5·2–7·8) in 1996 to 2·9% (2·1–3·5) in 2015. 
Conversely, the proportions of under-5 deaths due to 
congenital abnormalities increased from 9% (8·1–11·0) 
in 1996 to 20% (18·1–21·5) in 2015. Congenital 
abnormalities have become the leading cause of under-5 
deaths since 2009. The contribution of preterm birth 
1996 2015
Estimated number of deaths Cause-speciﬁ c mortality 
rate (per 1000 livebirths)
Estimated number of deaths Cause-speciﬁ c mortality 
rate (per 1000 livebirths)
Children aged 0–59 months
Congenital abnormalities 62 700 (50 200–69 800) 4·5 (3·6–5·1) 35 700 (28 400–45 200) 2·1 (1·7–2·7)
Preterm birth complications 88 800 (76 500–101 200) 6·4 (5·5–7·3) 30 900 (24 200–40 800) 1·8 (1·4–2·4)
Injury 126 100 (83 400–146 700) 9·1 (6·0–10·6) 26 600 (21 000–33 400) 1·6 (1·3–2·0)
Intrapartum-related events 97 600 (84 600–111 400) 7·1 (6·1–8·1) 26 100 (20 500–34 600) 1·5 (1·2–2·0)
Pneumonia 158 200 (129 800–163 000) 11·5 (9·4–11·8) 22 200 (15 900–28 000) 1·3 (0·9–1·6)
Diarrhoea 48 700 (32 300–49 400) 3·5 (2·3–3·6) 5300 (3400–6900) 0·3 (0·2–0·4)
Sepsis or meningitis 20 600 (14 200–20 800) 1·5 (1·0–1·5) 5000 (3800–6500) 0·3 (0·2–0·4)
Other conditions 97 900 (70 400–111 400) 7·1 (5·1–8·1) 29 700 (24 200–40 800) 1·7 (1·4–2·3)
Neonates aged 0–27 days
Preterm birth complications 85 800 (73 700–97 900) 6·2 (5·3–7·1) 29 000 (22 600–38 800) 1·7 (1·3–2·3)
Intrapartum-related events 97 500 (84 400–111 200) 7·1 (6·1–8·1) 25 700 (20 000–34 100) 1·5 (1·2–2·0)
Congenital abnormalities 36 200 (29 900–42 800) 2·6 (2·2–3·1) 16 800 (13 100–22 700) 1 (0·8–1·4)
Pneumonia 56 600 (48 100–66 000) 4·1 (3·5–4·8) 5400 (4100–7200) 0·3 (0·2–0·4)
Injury 32 500 (26 200–40 100) 2·4 (1·9–2·9) 4600 (3600–6200) 0·3 (0·2–0·4)
Sepsis or meningitis 5600 (4000–7400) 0·4 (0·3–0·5) 2500 (1800–3500) 0·1 (0·1–0·2)
Diarrhoea 2700 (2100–3400) 0·2 (0·1–0·2) 500 (300–600) 0 (0–0)
Tetanus 6500 (4100–9100) 0·5 (0·3–0·7) .. ..
Other conditions 31 200 (25 800–36 600) 2·3 (1·9–2·7) 9000 (6900–12 200) 0·5 (0·4–0·7)
Children aged 1–59 months
Injuries 93 600 (73 500–113 600) 6·8 (5·3–8·2) 22 000 (16 700–27 800) 1·3 (1·0–1·6)
Congenital abnormalities 26 600 (18 300–29 300) 1·9 (1·3–2·1) 19 000 (13 000–25 100) 1·1 (0·8–1·5)
Pneumonia 101 600 (75 100–104 000) 7·4 (5·4–7·5) 16 800 (11 100–21 700) 1·0 (0·7–1·3)
Diarrhoea 45 900 (30 000–46 600) 3·3 (2·2–3·4) 4800 (3100–6300) 0·3 (0·2–0·4)
Meningitis 14 600 (8 500–15 100) 1·1 (0·6–1·1) 2100 (1500–2800) 0·1 (0·1–0·2)
Preterm birth complications 3000 (2200–3800) 0·2 (0·2–0·3) 1900 (1300–2500) 0·1 (0·1–0·1)
Pertussis 2200 (0–10 200) 0·2 (0·0–0·7) 1400 (1300–1400) 0·1 (0·1–0·1)
Measles 2400 (1500–3100) 0·2 (0·1–0·2) 500 (300–900) 0·0 (0·0–0·1)
Intrapartum-related events 100 (100–200) 0·0 (0·0–0·0) 400 (300–600) 0·0 (0·0–0·0)
HIV/AIDS 300 (200–600) 0·0 (0·0–0·0) 400 (200–800) 0·0 (0·0–0·0)
Malaria .. .. .. ..
Other conditions 55 800 (36 300–64 700) 4·0 (2·6–4·7) 18 800 (13 700–24 400) 1·1 (0·8–1·4)
Data are n (95% UR) or rate (95% UR). Other conditions in children aged 1–59 months included causes originating during the perinatal period, cancer, severe malnutrition, 
and other speciﬁ ed causes. Intrapartum-related events were previously referred to as birth asphyxia. UR=uncertainty range. Blank cells indicate that less than 100 deaths were 
estimated for the condition. 
Table 2: Estimated numbers of child deaths and mortality rates by cause in China in 1996 and 2015
For the Maternal and Child 
Epidemiology website see 
http://tinyurl.com/Hopkins-
MNCH-Chinacod-openacce
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complications and intrapartum-related events were more 
stable in this period, ranging between 12·7% (12·4–15·7) 
and 19·2% (17·4–21·0).
In 1996–2015, cause-speciﬁ c mortality rates decreased 
with striking, albeit varying ARRs (table 1). The causes of 
death with the most rapid decline in children younger 
than 5 years were infectious diseases, including neonatal 
tetanus, diarrhoea, and pneumonia, with ARRs of greater 
than 10% at the national level and across regions. All 
other causes decreased at ARRs greater than that needed 
to achieve MDG 4 (4·4%), with the exception of congenital 
abnormalities. The reduction of mortality due to 
congenital abnormalities was particularly slow in the 
central region (ARR 3·5% [95% UR 1·4–6·2]) and the 
western region (2·6% [0·0–6·2]).
The cause-of-death composition also varied across age 
groups. Distributions of age-speciﬁ c causes-of-death 
are shown in the appendix (p 18). Intrapartum-related 
events, preterm birth complications, and congenital 
abnormalities were the leading causes in the early 
neonatal period (0–6 days). Collectively, they accounted for 
over three-quarters of all early neonatal deaths. For deaths 
occurring in the late neonatal period (7–27 days), 
pneumonia replaced intrapartum-related events and 
ranked among the top three leading causes. Congenital 
abnormalities, pneumonia, and injuries were the leading 
causes of death in children who died at the ages of 
28 days–5 months and 6–11 months. After the ﬁ rst year of 
life, injuries became the leading cause, contributing 
41·1% (95% UR 38·8–42·9) of deaths in children 
aged 12–23 months and 53·8% (51·4–57·5) of deaths in 
children aged 24–59 months. The relative importance of 
preterm birth complications dropped sharply across the 
six age groups once children had survived the neonatal 
period. The contribution of congenital abnormalities to 
mortality remained high through infancy, after which it 
declined. Injuries started to gain prominence after the 
neonatal period and became dominant after the ﬁ rst year 
of life (appendix p 18).
The cause distribution was also somewhat diﬀ erent 
between rural and urban areas (appendix p 19). In rural 
areas, congenital abnormalities and preterm births were 
followed by injuries as the leading causes, whereas in 
urban areas intrapartum-related events were ranked 
third. The distribution of causes of under-5 deaths also 
diﬀ ered by region (appendix p 19). Whereas congenital 
abnormalities, preterm birth complications, and injuries 
were the leading causes in the eastern and central 
regions, pneumonia caused more deaths than did 
injuries in the western region.
The western rural area is the least developed area of the 
six region-residency strata. Under-5 mortality rate in the 
western rural area was estimated to be 22·4 (95% UR 
18·1–28·1) per 1000 livebirths in 2015, at least twice that 
of under-5 mortality rate in other region-residency strata 
(ﬁ gure 5). The western rural area was also the only 
stratum with an infectious disease (pneumonia) as the 
leading cause, whereas congenital abnormalities were 
the leading cause in all other strata. Injuries contributed 
to higher mortality rates in rural areas than urban areas 
Figure 4: Cause of mortality in children younger than 5 years in China, 1996–2015
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across all regions. The gap in mortality rates between 
western rural and eastern urban areas widened for major 
non-infectious causes in 1996–2015. For example, the 
ratio of mortality rates due to congenital abnormalities 
between the two areas increased from 1·2 in 1996 to 2·8 
in 2015, and the ratio of intrapartum-related events 
increased from 4·1 in 1996 to 5·9 in 2015.
Our MCHSS based cause-speciﬁ c mortality fractions 
estimates for 2015 in children younger than 5 years were 
similar to those derived by Song and colleagues16 (appendix 
p 20). The accuracy of the cause-speciﬁ c mortality fractions 
was estimated to be 0·92. One exception was the fraction 
of congenital abnormalities, which was estimated to be 
20% in this study compared with 14% by Song and 
colleagues.16 More discrepancies are noted in the neonatal 
period; despite overall good agreement between the 
two sets of estimates (cause-speciﬁ c mortality fractions 
accuracy of 0·96), the fraction of congenital abnormalities 
was greater in our study than that in Song and colleagues’ 
study (18% vs 11%). In children aged 1–59 months, the 
agreement was good (cause-speciﬁ c mortality fractions 
accuracy is 0·94), with similar fractions of major causes, 
including injuries, congenital abnormalities, pneumonia, 
and diarrhoea.
Discussion
China has made remarkable strides in improving child 
survival in 1996–2015. It has achieved an impressive 
average annual rate of decline of under-5 mortality rate of 
8·2% compared with the global ﬁ gure of 3·7% in this 
period. Based on our estimates, suﬃ  cient progress (ie, at 
an ARR of at least 4·4% per year to achieve the MDG 4 
target) has been achieved across regions, residency, age 
groups, and cause categories.
The progress coincided with China’s widespread 
socioeconomic development in the past two decades.20,21 
This development includes, for example, the 
improvement in girls’ education through achievement of 
9 year compulsory education for all and narrowing the 
gender gap in years of education from 1·3 years in 2000 
to 0·8 years in 2014.20,21 National commitment to the 
improvement of maternal and child survival and health 
could be another important contributor, manifested by 
strengthened strategic legislation (eg, the Law on 
Maternal and Infant Health Care) and institutionalised 
policy frameworks (eg, the National Action Plan for the 
Development of Children).20,21 Rigorous quantitative and 
qualitative research is still needed to understand the 
mechanisms through which these national development 
and action plans have been successful.
China oﬃ  cially eliminated neonatal tetanus in 2012.22 
Despite not having a national programme on maternal 
tetanus toxoid immunisation, this success was credited to 
increased institutional delivery through the Safe 
Motherhood Initiative and the national Program to 
Reduce Maternal Mortality and Eliminate Neonatal 
Tetanus to improve local obstetric infrastructure, establish 
a fast-channel referral mechanism for pregnant women 
at labour, subsidise institutional delivery, and oﬀ er 
community-based health education.20,23 More research is 
needed to establish the contribution of economic 
development in addition to these national programmes.24 
China outperformed most of the 74 Countdown to 2015 
countries (countries with high under-5 mortality rate, 
large numbers of under-5 deaths, or both) in its progress 
on major infectious causes, such as pneumonia and 
diarrhoea.25 Improved socioeconomic status, water, 
sanitation, nutrition, and access to integrated 
management of childhood illness could be contributors 
to success.10,26,27 Major causes of neonatal mortality, such 
as preterm birth complications and intrapartum-related 
events, have also been steadily declining, which might be 
associated with increased quality of institutional delivery 
and neonatal resuscitation.28,29 Although existing research 
has implied causal relationships between some of these 
interventions and cause-speciﬁ c mortality rates, more 
rigorous evaluation studies that can adequately establish 
causal relationships are needed.
Despite the progress, 181 600 children died before their 
ﬁ fth birthday in China in 2015. Major causes of child 
deaths included congenital abnormalities, preterm birth 
complications, and injuries. The list of leading causes is 
similar to that in high-income countries, such as the 
USA.30 Congenital abnormalities are not only the leading 
cause, but also one that becomes increasingly important. 
Previous studies suggest that integrated preventive and 
treatment strategies combining political commitment, 
folic acid supplementation, and improved insurance 
coverage of surgeries addressing congenital heart 
diseases could be eﬀ ective.31–33 Staple food fortiﬁ cation 
with folic acid could also be considered.20,32 Primary and 
secondary prevention of preterm birth complications and 
Figure 5: Cause-speciﬁ c mortality rate in children younger than 5 years by region-residency strata in China, 2015
Causes with mortality rate of less than 0·5 per 1000 livebirths are not labelled.
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injuries should receive more attention from the medical 
community, the government, and the general public. 
Eﬀ ective interventions could include antenatal 
corticosteroids and kangaroo mother care for preterm 
births, and seat-belts and helmets to prevent road traﬃ  c 
injuries.34,35 More research is needed to further 
understand the eﬀ ectiveness of these interventions in the 
Chinese context and, if eﬀ ective, how to implement these 
interventions at scale.2
Despite a similar pace of decline across regions, almost 
half of all deaths in children younger than 5 years 
occurred in the least developed western region in 2015. 
The mortality rate in the western region was more than 
three times that of the most developed eastern region, 
and this gap increased by 10% since 1996. Overall, 
inadequate health service infrastructures and low health 
expenditure due to economic underdevelopment are 
thought to have resulted in limited access and use of 
health services in mothers and children, which led to 
inequity in child survival status in the western region.36,37 
Although the quantity of MCH workers did not seem to 
be an issue in this region, their education level was worse 
than that in the other two regions.38 This might have 
aﬀ ected the quality of child health services provided. 
Investment in strategies to encourage the ﬂ ow of better-
educated and well trained MCH staﬀ  to the western 
region could be a policy option. MCH leadership and 
champions are also needed to improve child survival in 
the less developed areas. Clearly, the regional disparities 
in child mortality need to be systematically addressed in 
the SDG era. Child survival policy, programmes, and 
resources targeting the western region should receive 
more attention.
With 80% of under-5 deaths in 2015, rural areas should 
be another focus for child survival in the SDG era. 
Several rural-focused national policies and programmes, 
such as the Program to Reduce Maternal Mortality and 
Eliminate Neonatal Tetanus and the Safe Motherhood 
Initiative, have been in place since the early 2000s 
through enhanced subsidies of institutional delivery in 
rural women. These programmes might have contributed 
to the steady decline of child mortality in rural China and 
more evidence is needed to support this claim.20 Ensuring 
continued success of these programmes is crucial, 
especially in hard-to-reach areas where child mortality is 
probably the highest. Rapid urbanisation has been 
shifting the burden of deaths in children younger than 
5 years from rural to urban areas, yet the survival, health, 
and wellbeing of migrant children or children of migrant 
parents who are left behind are poorly understood.39 
Injuries and pneumonia should receive more attention 
from the central and local government, the medical and 
public health community, and the general public in rural 
areas whereas congenital abnormalities and preterm 
birth complications are the priorities in urban areas.
More than half of under-5 deaths in China in 2015 were 
of neonates. Based on the estimated age-speciﬁ c cause-of-
death distributions, interventions targeting intrapartum-
related events should focus on the early neonatal period. 
Programmes for preterm birth complications need to 
target the entire ﬁ rst month of life. Interventions 
addressing congenital abnormalities are important 
throughout the ﬁ rst year of life. After the age of 1 year, 
child survival policy and programmes should clearly 
concentrate on preventing and treating injuries. Research 
to obtain similar understanding of the age-speciﬁ c cause 
compos ition is needed in other LMICs to help policy 
makers and programme managers to better prioritise and 
allocate scarce resources by age.
Our data source, MCHSS, has been growing and 
evolving since its establishment. Reporting completeness 
has improved over time and the proportion of causes 
ascertained by medical certiﬁ cation has increased, aided 
in part by increased use of hospitals.40,41 Most deaths 
ascertained by verbal autopsy were due to injuries, which 
are relatively accurately identiﬁ ed by this method.42 
Increasing completeness suggests that surveillance 
capability and data quality might have improved. However, 
the pace of improvement might not have been even. For 
example, neonatal mortality rate in the western region 
increased in 2000–03 before resuming the downward 
trend in 2004 (ﬁ gure 2B). This small peak in the trend line 
might not be real, given the rapid decline in neonatal 
mortality rate in other regions and in the national under-5 
mortality rate. Instead, the increase in mortality rate 
observed during that period could reﬂ ect improved 
surveillance capacity in detecting neonatal deaths after 
2000 in the western region.
Our study has some limitations. First, MCHSS 
considered local capacity when sampling prefectural-
level urban cities and rural counties, which could have 
introduced biases. Second, the sampling probabilities 
were calculated using total population under surveillance 
and region-residence-stratum-speciﬁ c census population 
estimates that are the best available. Because a census is 
only done every 10 years and China has been experiencing 
rapid urbanisation, the sampling probabilities are 
approximations. Third, the deﬁ nition of livebirths was 
restricted to those born after 28 weeks of gestation, which 
could underestimate neonatal and under-5 mortality 
rates and the contribution of major neonatal causes, 
especially preterm birth complications. Given the 
relatively small burden of those born alive before 
28 weeks, this bias is likely to be small. We did a 
sensitivity analysis comparing estimates based on the 
narrow deﬁ nition of livebirth and that of all livebirths in 
selected sites where information on both was collected 
and found only small diﬀ erences (data not shown). A 
plan is being developed to update the livebirth deﬁ nition 
in MCHSS. This update should be easier to implement 
now because China has oﬃ  cially adopted the two-child 
policy. Lastly, given the nature of sample surveillance 
systems in which coverage is overall low at the national 
level, trends based on raw data are not smooth (appendix 
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p 21). We have chosen to smooth the raw data and ﬁ t to 
the UN IGME estimates. The process might have 
inadvertently masked real short-term trends.
Despite the additional adjustments performed, 
however, MCHSS raw estimates fall within the 
uncertainty of UN IGME estimates for most years 
(appendix p 21). We also published in 2014 the national 
trends of under-5 mortality rate and neonatal mortality 
rate for China for the period 2000–12.43 The under-5 
mortality rate estimates agree well with those produced 
by UN IGME, but the neonatal mortality rate estimates 
are signiﬁ cantly lower than those of UN IGME in 
1996–2005 and start to converge to the UN IGME 
estimates after 2006. In the 2014 paper, input data from 
MCHSS and other sources were used, including vital 
registration and maternal and child annual reporting. 
Estimation methods were also diﬀ erent from those used 
in the UN IGME. That the two sets of relatively 
independent estimates agree reasonably well in 10 years 
is encouraging. Similarly, our estimates of cause-of-death 
distributions generally agree with estimates produced by 
Song and colleagues.16
China’s Western Development is arguably one of the 
biggest development initiatives in the world. With a 
combination of socioeconomic development and regional 
MCH programmes, such as the Program to Reduce 
Maternal Mortality and Eliminate Neonatal Tetanus which 
was ﬁ rst piloted regionally in 2000,20 the western region 
has had great progress in improving child survival. 
Lessons learnt in this process, particularly those assessed 
by rigorous evaluations, are probably the most relevant to 
other LMICs. However, not all of China’s experiences are 
readily transferrable to other countries and context. For 
example, institutional delivery rate has increased by about 
30% in urban areas (76·5% in 1996 to 99·7% in 2012) and 
91% in rural areas (51·7% in 1996 to 98·8% in 2012).44 
These increases might have contributed to China’s 
advances in child, and particularly neonatal, survival. But 
such a rapid increase in institutional delivery rate could be 
challenging to replicate in other LMICs. In addition to 
coverage, quality of institutional delivery rate is also a key 
consideration. For low-income settings not ready for the 
scale-up of institutional delivery rate, community-based 
neonatal interventions, such as kangaroo mother care and 
chlorhexidine cord cleansing,45 could be suitable options.
The experiences of establishing and improving MCHSS 
could also prove informative to other LMICs where 
adequate vital or sample registration system is unavailable 
or of low quality. Where access to health care is high, a dual 
system of collecting vital events through community and 
health facilities can be attempted, as was done in MCHSS, 
so that crosschecking can be routinely implemented 
during quality control. Other forms of data triangulation 
across sectors and routine quality control mechanisms are 
also possible lessons from which other LMICs could learn.
We consider our transition from model-based estimates 
to estimates based on empirical data for China an 
important step forward. This approach not only helps 
improves the validity of our estimates, but also increases 
the use of sample registration system data for national 
policy making and international exchange. Our study 
shows that strengthened civil registration and vital 
statistics could support and inform health policy and 
planning and help global health debates. We hope that 
China’s experiences of developing MCHSS and achieving 
rapid improvement of child survival can contribute to the 
discussion on strengthening civil registration and vital 
statistics and on continued investment in child survival 
in LMICs in the SDG era.
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